Fred Hutch public health researchers Drs. Scott Ramsey and Veena Shankaran welcomed stakeholders to the 2024 Value in Cancer ...

As part of an international collaboration, Fred Hutch scientists provided structural information that helped reveal how two ...

Three Fred Hutch Cancer Center researchers received a five-year, $3.8 million award from the National Cancer Institute to ...

On Aug. 10, 2024, more people than ever before experienced cheers, sun and community as they joined up in Seattle and ...

Dr. Nicole Fleming, a gynecologic oncologist specializing in the treatment of gynecologic malignancies with both surgical and ...

Fred Hutch Cancer Center researchers developing immunotherapies using engineered adaptive immune system cells have received ...

Fred Hutch Cancer Center brought together a host of experts on November 2 to share tips, tools, resources and strategies for ...

As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible ...

The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, ...

Basic science discoveries underlie the innovative cures and treatments we develop at Fred Hutch. Our research teams strive to understand the normal molecular functioning of cells as well as the ...

This study will look at the use of new technologies for cancer screening called Multi-Cancer Detection (MCD) tests. The goal is to learn more about these tests and find out if they can help people ...